Key Insights• According to the research report, "China Hydrogel Market Overview, 2031," published by Actual Market Research, the China Hydrogel Market is anticipated to add to more than USD 2.42 Billion by 2026-31.• China's hydrogel market benefits from a large healthcare industry, a well-developed chemical manufacturing base, and substantial domestic research capabilities in polymer science, biomaterials, and biomedical engineering. Universities, hospitals, and research institutions are investigating hydrogel technologies for wound management, tissue regeneration, drug delivery, and biomedical applications. The Chinese Academy of Sciences and universities such as Kunming University of Science and Technology contribute to research into advanced hydrogel formulations, demonstrating the country's growing capabilities in developing specialised materials. • The country's established manufacturing infrastructure creates opportunities to scale hydrogel production and integrate new formulations into medical products and industrial technologies. Domestic production capabilities, a large internal market, and ongoing research investment support the development of locally engineered materials. Nevertheless, hydrogel manufacturers must address quality control, production costs, competition, and the technical challenges involved in transferring laboratory developed formulations into reliable commercial products.Market Outlook• China's hydrogel market is expected to benefit from continued investment in healthcare technology, biomedical research, and advanced materials manufacturing. Research into wound-care materials, tissue engineering, regenerative medicine, and controlled drug delivery provides opportunities for companies developing specialised hydrogel formulations.

Commercial adoption will depend on demonstrating product safety, consistent performance, cost-effectiveness, and practical benefits for healthcare providers and industrial users.• China's large medical technology manufacturing base provides opportunities for domestic suppliers to develop hydrogel-based products and establish partnerships with medical device manufacturers, hospitals, and research organisations. Government support for innovation and domestic manufacturing may further encourage investment in advanced biomaterials. Companies that can combine reliable production, competitive pricing, and strong technical capabilities may be better positioned to serve domestic demand and expand internationally. Policies • Medical devices containing or based on hydrogels are regulated in China under the Regulations on the Supervision and Administration of Medical Devices, revised through State Council Order No. 739 in 2021. The National Medical Products Administration (NMPA) oversees medical device registration and supervision, with classification determining the applicable registration or filing requirements. Manufacturers must provide appropriate technical documentation and demonstrate product safety and performance; additional testing, biological evaluation, or clinical evidence may be required depending on the device and its intended use. • In July 2025, the NMPA issued Announcement No. 63 of 2025, introducing measures to optimise lifecycle regulation and support innovation in high-end medical devices, including devices involving new biomedical materials. The measures address areas such as technical standards, registration review, and post-market supervision.

These provisions are relevant to developers of innovative hydrogel-based medical products because they emphasise regulatory support for technological development alongside appropriate safety and quality oversight.Industry Statistics• According to the China Association of Medical Equipment, China's medical equipment market reached approximately RMB 1.44 trillion in 2025, equivalent to around USD 208 billion, maintaining its position as the world's second-largest national market. The association reported that the market expanded by 60.5% between 2021 and 2025. These figures demonstrate the scale of China's healthcare technology sector, which provides a substantial industrial and commercial environment for the development of advanced biomaterials. However, they represent the broader medical equipment market rather than hydrogel-specific revenue. • The National Medical Products Administration reported that China approved 76 innovative medical devices in 2025, an increase of approximately 17% compared with 2024. During the same year, the authority approved 14,187 medical device registration applications across initial, renewal, and change registrations. These figures illustrate continued activity in medical device innovation and regulatory approvals, although they do not indicate how many approvals involved hydrogel-based products.• China's medical equipment exports reached approximately USD 45.8 billion in 2025, according to the China Association of Medical Equipment.

This represented an increase of 62.4% compared with 2019, reflecting the country's expanding role in international medical technology supply chains. While these export figures cover medical equipment broadly rather than hydrogel materials specifically, they provide context for the manufacturing infrastructure and export channels potentially available to Chinese developers of advanced medical products.Segment AnalysisChina Hydrogel Market By Product Type• Synthetic Hydrogel represents a major product category in China, supported by extensive applications in personal care and hygiene products, wound dressings, contact lenses, and pharmaceutical formulations. Synthetic hydrogels provide controlled swelling, high liquid absorption, mechanical stability, and consistent performance, making them suitable for applications requiring specific material characteristics and reliable manufacturing quality. Demand is supported by China's large consumer goods manufacturing base, expanding healthcare sector, and established polymer processing industry. Their adaptability across different formulations and performance grades supports use in disposable hygiene products, medical devices, and specialized industrial applications. • Natural Hydrogel is gaining attention in China due to growing interest in biocompatible materials, renewable raw materials, and sustainable product development. Hydrogels based on alginate, gelatin, agar, cellulose, collagen, and other naturally derived polymers are used in wound care, pharmaceutical formulations, cosmetics, food-related applications, and biomedical research.

Their ability to retain water and interact with biological systems makes them relevant to tissue engineering, regenerative medicine, and advanced wound management. China's expanding biotechnology sector, pharmaceutical research capabilities, and academic institutions provide opportunities for developing natural hydrogel formulations. China Hydrogel Market By Composition• Polyacrylate represents an important composition category in China, particularly through sodium polyacrylate and related superabsorbent polymer formulations used in disposable hygiene products. These materials provide high liquid absorption and retention, making them suitable for diapers, feminine hygiene products, and adult incontinence products. Additional applications include selected agricultural water-retention products and specialized absorbent systems. Demand is supported by China's large hygiene product manufacturing base, extensive consumer market, and established polymer processing capabilities. Domestic manufacturers benefit from opportunities to supply absorbent materials to consumer goods producers and other industrial users. • Polyacrylamide hydrogels are used in selected agricultural, industrial, laboratory, and biomedical applications in China.

In agriculture, suitable formulations can improve water retention in growing media and support moisture management in horticulture and landscaping. Laboratory applications include polyacrylamide-based electrophoresis systems used in biochemical and molecular biology research, while specialized formulations are investigated for biomaterial development and controlled drug delivery. Demand is influenced by agricultural water-management requirements, scientific research, and the use of polymer-based materials in industrial processes. China Hydrogel Market By Application• Personal Care & Hygiene represents a major application area for hydrogels in China, supported by demand for disposable diapers, feminine hygiene products, adult incontinence products, and selected skincare and cosmetic formulations. Superabsorbent hydrogel materials retain substantial quantities of liquid relative to their weight, helping improve product dryness, comfort, and leakage control. China's large population, extensive hygiene product manufacturing industry, and expanding consumer goods distribution networks support demand for absorbent materials. • Wound Care is an important application for hydrogels in China, particularly in the management of burns, chronic wounds, surgical wounds, and injuries requiring moisture control. Hydrogel dressings help maintain a moist wound environment, rehydrate selected wound surfaces, and support autolytic debridement where clinically appropriate.

Demand is supported by expanding healthcare services, hospital treatment requirements, an ageing population, and growing awareness of advanced wound management products. Hydrogel based dressings are used in hospitals, specialist clinics, and home healthcare settings, depending on wound characteristics and clinical recommendations. Considered in this report• Historic Year: 2020• Base year: 2025• Estimated year: 2026• Forecast year: 2031Aspects covered in this report• Hydrogel Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Synthetic Hydrogel• Natural Hydrogel• Hybrid HydrogelBy Application• Personal Care & Hygiene• Wound Care• Contact Lenses• Agriculture• Drug Delivery• OthersBy Composition• Polyacrylate• Polyacrylamide• Silicone-modified Hydrogels• Others (Agar-based, alginate-based, gelatin-based, cellulose-based and other formulations).